Results
|
|
5041.
|
|
|
|
5042.
|
|
|
|
5043.
|
|
|
|
5044.
|
|
|
|
5045.
|
|
|
|
5046.
|
|
|
|
5047.
|
|
|
|
5048.
|
|
|
|
5049.
|
|
|
|
5050.
|
|
|
|
5051.
|
|
|
|
5052.
|
|
|
|
5053.
|
|
|
|
5054.
|
|
|
|
5055.
|
|
|
|
5056.
|
|
|
|
5057.
|
|
|
|
5058.
|
|
|
|
5059.
|
|
|
|
5060.
|
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. [electronic resource] by
- Cohen, Calvin J
- Andrade-Villanueva, Jaime
- Clotet, Bonaventura
- Fourie, Jan
- Johnson, Margaret A
- Ruxrungtham, Kiat
- Wu, Hao
- Zorrilla, Carmen
- Crauwels, Herta
- Rimsky, Laurence T
- Vanveggel, Simon
- Boven, Katia
Producer: 20110729
In:
Lancet (London, England) vol. 378
Availability: No items available.
|